Legal basis: Notice on Incorporating Related Drugs into Medical Insurance Special Drugs
First, the scope of special medical insurance drugs was defined. The special medical insurance drugs currently used and managed in our province were negotiated by the National Health Planning Commission and included in the national basic medical insurance, industrial injury insurance and maternity insurance drug list (version 20 17) and the anti-tumor molecular targeted drugs in document No.54 issued by Ministry of Human Resources and Social Security. In accordance with the voluntary principle of enterprises, it is included in the management scope of special medical insurance drugs through unified negotiation by ministries and agencies.
Second, it is clear that medical insurance special drugs are managed according to Class B drugs of basic medical insurance, and the expenses incurred by the insured for using special drugs due to serious and serious diseases are included in outpatient specific diseases (projects) or hospitalization medical expenses. All districts and cities should do a good job in the convergence of new and old special drug treatment policies, and coordinate the fund payment policies of various special drugs in different types of insurance. The specific payment ratio (including basic medical insurance and serious illness insurance) is determined by each district and city.